Respiratory Inhalers Global Strategic Business Report 2023:
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Marked Reduction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The
/PRNewswire/ -- The "Respiratory Inhalers: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for...
Interim data from phase III HAVEN 7 study reinforce Hemlibra's efficacy and safety in infants with severe haemophilia A without factor VIII inhibitors1New and updated data support use of Polivy in diffuse
Investegate announcements from F. Hoffmann-La Roche Ltd, Roche to present data at ASH 2022 showcasing strength of haematology portfolio and expanding into new areas to address more patient needs